To implement the analysis of OPC dysfunction in ALS and to study the effects of pharmacological compounds targeting GPR17, we moved to in vitro studies using primary cultures of spinal cord OPCs from SOD1G93A mice. This evidence concerns the gene GPR17 and amyotrophic lateral sclerosis.